Literature DB >> 11157742

NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.

E Kroon1, U Thorsteinsdottir, N Mayotte, T Nakamura, G Sauvageau.   

Abstract

Here we describe hemopoietic chimeras serving as a mouse model for NUP98-HOXA9-induced leukemia, which reproduced several of the phenotypes observed in human disease. Mice transplanted with bone marrow cells expressing NUP98-HOXA9 through retroviral transduction acquire a myeloproliferative disease (MPD) and eventually succumb to acute myeloid leukemia (AML). The NUP98 portion of the fusion protein was shown to be responsible for transforming a clinically silent pre-leukemic phase observed for Hoxa9 into a chronic, stem cell-derived MPD. The co-expression of NUP98-HOXA9 and Meis1 accelerated the transformation of MPD to AML, identifying a genetic interaction previously observed for Hoxa9 and Meis1. Our findings demonstrate the presence of overlapping yet distinct molecular mechanisms for MPD versus AML, illustrating the complexity of leukemic transformation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157742      PMCID: PMC133485          DOI: 10.1093/emboj/20.3.350

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  Cooperative interactions between HOX and PBX proteins mediated by a conserved peptide motif.

Authors:  M L Phelan; I Rambaldi; M S Featherstone
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

2.  Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins.

Authors:  C P Chang; W F Shen; S Rozenfeld; H J Lawrence; C Largman; M L Cleary
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

3.  Chronic myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98/HOXA9 fusion.

Authors:  K F Wong; C C So; Y L Kwong
Journal:  Cancer Genet Cytogenet       Date:  1999-11

4.  Defining roles for HOX and MEIS1 genes in induction of acute myeloid leukemia.

Authors:  U Thorsteinsdottir; E Kroon; L Jerome; F Blasi; G Sauvageau
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

5.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.

Authors:  T R Golub; D K Slonim; P Tamayo; C Huard; M Gaasenbeek; J P Mesirov; H Coller; M L Loh; J R Downing; M A Caligiuri; C D Bloomfield; E S Lander
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

6.  Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.

Authors:  K R Calvo; D B Sykes; M Pasillas; M P Kamps
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

7.  HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis.

Authors:  C A Schnabel; Y Jacobs; M L Cleary
Journal:  Oncogene       Date:  2000-02-03       Impact factor: 9.867

8.  A safe packaging line for gene transfer: separating viral genes on two different plasmids.

Authors:  D Markowitz; S Goff; A Bank
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

9.  The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors.

Authors:  R G Hawley; A Z Fong; M Lu; T S Hawley
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

10.  Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo.

Authors:  G Sauvageau; U Thorsteinsdottir; C J Eaves; H J Lawrence; C Largman; P M Lansdorp; R K Humphries
Journal:  Genes Dev       Date:  1995-07-15       Impact factor: 11.361

View more
  69 in total

1.  Dual actions of Meis1 inhibit erythroid progenitor development and sustain general hematopoietic cell proliferation.

Authors:  Mi Cai; Ellen M Langer; Jennifer G Gill; Ansuman T Satpathy; Jörn C Albring; Wumesh KC; Theresa L Murphy; Kenneth M Murphy
Journal:  Blood       Date:  2012-06-04       Impact factor: 22.113

2.  Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.

Authors:  Nayan J Sarma; Nabeel R Yaseen
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

3.  Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9.

Authors:  Paul M Ayton; Michael L Cleary
Journal:  Genes Dev       Date:  2003-09-02       Impact factor: 11.361

4.  Differential and common leukemogenic potentials of multiple NUP98-Hox fusion proteins alone or with Meis1.

Authors:  Nicolas Pineault; Carolina Abramovich; Hideaki Ohta; R Keith Humphries
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

5.  Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.

Authors:  Akiko Takeda; Nayan J Sarma; Anmaar M Abdul-Nabi; Nabeel R Yaseen
Journal:  J Biol Chem       Date:  2010-03-16       Impact factor: 5.157

Review 6.  NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins.

Authors:  Takuro Nakamura
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

7.  Enhanced expression of the EVI1 gene in NUP98/HOXA-expressing leukemia cells.

Authors:  Minenori Eguchi-Ishimae; Mariko Eguchi; Kazuma Ohyashiki; Tetsuya Yamagata; Kinuko Mitani
Journal:  Int J Hematol       Date:  2009-02-26       Impact factor: 2.490

8.  Protein kinase C-mediated phosphorylation of the leukemia-associated HOXA9 protein impairs its DNA binding ability and induces myeloid differentiation.

Authors:  Ulka Vijapurkar; Neal Fischbach; Weifang Shen; Christian Brandts; David Stokoe; H Jeffrey Lawrence; Corey Largman
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia.

Authors:  Ying-Wei Lin; Christopher Slape; Zhenhua Zhang; Peter D Aplan
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

10.  Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.

Authors:  Gang G Wang; Martina P Pasillas; Mark P Kamps
Journal:  Blood       Date:  2005-03-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.